Rainmaker Granted Patent That Has the Potential to Almost Double Output of Air-to-Water Systems
Feb 26, 2018 12:00 pm UTC| Business
PETERBOROUGH, Ontario, Feb. 26, 2018 -- via OTC PR WIRE– Rainmaker Worldwide (OTC:RAKR) announces the granting of a patent that dramatically improves the efficiency of harvesting water vapor from the air. This patent...
Algold Increases Gold Resources at Tijirit
Feb 26, 2018 12:00 pm UTC| Business
MONTREAL, Feb. 26, 2018 -- ALGOLD RESOURCES LTD. (TSX-V:ALG) (the “Corporation”) today announced an updated mineral Resource Estimate, prepared in accordance with the reporting guidelines as set out in National...
Feb 26, 2018 12:00 pm UTC| Business
Chirally pure and stable single enantiomers of bupropion achieved AXS-09 consists of esbupropion and dextromethorphan for CNS disorders Esbupropion is the chirally pure S-enantiomer of bupropion AXS-09 results in...
Horizon Pharma plc to Participate in the Cowen and Company 38th Annual Health Care Conference
Feb 26, 2018 12:00 pm UTC| Business
DUBLIN, Ireland, Feb. 26, 2018 -- Horizon Pharma plc (NASDAQ:HZNP) today announced that the company will present at the following conference in March: Cowen and Company 38th Annual Health Care Conference Date: March...
Mitek Hosts Telefónica, Accenture and Consult Hyperion on Expert Panel at Mobile World Congress
Feb 26, 2018 12:00 pm UTC| Business
SAN DIEGO and LONDON, United Kingdom, Feb. 26, 2018 -- Mitek (NASDAQ:MITK) (www.miteksystems.com), a global leader in mobile capture and identity verification software solutions, announced that Senior Vice President of...
Dorman Products, Inc. Reports Fourth Quarter and Fiscal 2017 Results, Issues Fiscal 2018 Guidance
Feb 26, 2018 12:00 pm UTC| Business
Highlights: Diluted earnings per share (EPS) of $0.65 on a GAAP basis, including $0.22 per share in tax and acquisition-related charges, compared to $0.83 last year. Adjusted diluted EPS of $0.87, up 5% compared to...
Feb 26, 2018 12:00 pm UTC| Business
RANCHO CORDOVA, Calif., Feb. 26, 2018 -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL) a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced the commercial...